Skip to Content

LUNG CANCER PANEL 1 [EGFR, ALK1] (SDL11823)

https://www.scanlabglobal.com/web/image/product.template/6212/image_1920?unique=18393fc
Tests EGFR and ALK mutations in tissue for NSCLC therapy. Positive results guide TKIs like gefitinib or crizotinib for lung cancer.

2,530.00 AED 2530.0 AED 2,530.00 AED

2,530.00 AED

Not Available For Sale

This combination does not exist.